To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
August 1, 2005
The Damon Runyon Foundation has announced a new partnership with Berlex, Inc., a U.S. affiliate of Schering AG, Germany (NYSE:SHR). Berlex Oncology has committed $134,000 over three years to support Don X. Nguyen, PhD (Damon Runyon Fellow '05-'08). Dr. Nguyen's research focuses on breast cancer and understanding the genetic basis of its often-lethal spread (metastasis) to the lung.